Innovative Licensing and Access Pathway The UK has launched a refreshed Innovative Licensing and Access Pathway (ILAP) to expedite the delivery of transformative medicines to patients in the NHS. This pathway, unique globally, allows medicine developers to collaborate with the national health system, regulators, and health technology assessment bodies from early clinical development stages. Key… Continue reading Innovative Licensing and Access Pathway